Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Minority Interest (2021 - 2025)

Roivant Sciences' Minority Interest history spans 5 years, with the latest figure at $705.0 million for Q4 2025.

  • For Q4 2025, Minority Interest rose 103.46% year-over-year to $705.0 million; the TTM value through Dec 2025 reached $705.0 million, up 103.46%, while the annual FY2025 figure was $499.6 million, 4.09% up from the prior year.
  • Minority Interest reached $705.0 million in Q4 2025 per ROIV's latest filing, up from $443.1 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $705.0 million in Q4 2025 to a low of $22.5 million in Q1 2021.
  • Average Minority Interest over 5 years is $362.7 million, with a median of $425.2 million recorded in 2023.
  • Peak YoY movement for Minority Interest: skyrocketed 1996.92% in 2022, then fell 29.97% in 2024.
  • A 5-year view of Minority Interest shows it stood at $22.5 million in 2021, then surged by 1996.92% to $471.6 million in 2022, then increased by 4.92% to $494.8 million in 2023, then dropped by 29.97% to $346.5 million in 2024, then soared by 103.46% to $705.0 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Minority Interest are $705.0 million (Q4 2025), $443.1 million (Q3 2025), and $470.3 million (Q2 2025).